Literature DB >> 2697987

Molecular genetics of severe insulin resistance.

L J Elsas1, N Longo, S Langley, L D Griffin, R C Shuster.   

Abstract

Leprechaunism and type A diabetes represent inborn errors of insulin resistance whose phenotypes suggested causation by mutations in the insulin receptor gene. Cells cultured from patients with leprechaunism specifically lacked high-affinity insulin binding. Partial but different degrees of impairment were observed in cells cultured from first-degree relatives. Different mutations in the insulin receptor's alpha subunit were proposed in different families (Ark-1, Atl, Minn, Mount Sinai) based on phenotype, cellular insulin binding, and insulin receptor structure. Molecular cloning and sequencing of mutant insulin receptor cDNA from family Ark-1 confirmed that the proband inherited a maternal missense and a paternal nonsense mutation in the alpha subunit and was a compound heterozygote. The insulin receptor was immunologically present on the plasma membrane of fibroblasts cultured from patients Ark-1 and Atl but was markedly reduced in cells from patients Minn and Mount Sinai. In cells from patient Minn, but not from patient Mount Sinai, the decreased number of insulin receptors was associated with reduced insulin receptor mRNA. In two families with the less severe form of insulin resistance, type A diabetes, mutations altered post-translational processing of the insulin receptor molecule. At a cellular level, these mutations of the alpha subunit of the insulin receptor shared defective binding and impaired stimulation of sugar transport by insulin. In family Atl, however, glucose uptake was constitutively increased. Thus, genetic variation in the insulin receptor gene causes a spectrum of inherited insulin-resistant syndromes and altered cellular signaling.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2697987      PMCID: PMC2589158     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  54 in total

1.  Mechanism of insulin action.

Authors:  J Espinal
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

2.  Monoclonal antibodies to the human insulin receptor that activate glucose transport but not insulin receptor kinase activity.

Authors:  J R Forsayeth; J F Caro; M K Sinha; B A Maddux; I D Goldfine
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

Review 3.  After insulin binds.

Authors:  O M Rosen
Journal:  Science       Date:  1987-09-18       Impact factor: 47.728

4.  An atypical insulin receptor with high affinity for insulin-like growth factors copurified with placental insulin receptors.

Authors:  H A Jonas; J D Newman; L C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin.

Authors:  C K Chou; T J Dull; D S Russell; R Gherzi; D Lebwohl; A Ullrich; O M Rosen
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

6.  Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity.

Authors:  Y Ebina; E Araki; M Taira; F Shimada; M Mori; C S Craik; K Siddle; S B Pierce; R A Roth; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

7.  Structural analysis of normal and mutant insulin receptors in fibroblasts cultured from families with leprechaunism.

Authors:  F Endo; N Nagata; J H Priest; N Longo; L J Elsas
Journal:  Am J Hum Genet       Date:  1987-09       Impact factor: 11.025

8.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose.

Authors:  L Ellis; E Clauser; D O Morgan; M Edery; R A Roth; W J Rutter
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

9.  Insulin-like and insulin-inhibitory effects of monoclonal antibodies for different epitopes on the human insulin receptor.

Authors:  R Taylor; M A Soos; A Wells; M Argyraki; K Siddle
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

10.  Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity.

Authors:  A Ullrich; A Gray; A W Tam; T Yang-Feng; M Tsubokawa; C Collins; W Henzel; T Le Bon; S Kathuria; E Chen
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  5 in total

1.  Genetic variation in insulin receptor beta-chain exons among members of familial type 2 (non-insulin-dependent) diabetic pedigrees.

Authors:  S C Elbein; L K Sorensen
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

2.  Activation of glucose transport by a natural mutation in the human insulin receptor.

Authors:  N Longo; S D Langley; L D Griffin; L J Elsas
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

3.  Reduced mRNA and a nonsense mutation in the insulin-receptor gene produce heritable severe insulin resistance.

Authors:  N Longo; S D Langley; L D Griffin; L J Elsas
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

4.  Severe insulin resistance and intrauterine growth deficiency associated with haploinsufficiency for INSR and CHN2: new insights into synergistic pathways involved in growth and metabolism.

Authors:  Sara G I Suliman; Juraj Stanik; Laura J McCulloch; Natalie Wilson; Emma L Edghill; Nadezda Misovicova; Daniela Gasperikova; Vilja Sandrikova; Katherine S Elliott; Lubomir Barak; Sian Ellard; Emanuela V Volpi; Iwar Klimes; Anna L Gloyn
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

5.  Genetic insulin resistance is a potent regulator of gene expression and proliferation in human iPS cells.

Authors:  Salvatore Iovino; Alison M Burkart; Kristina Kriauciunas; Laura Warren; Katelyn J Hughes; Michael Molla; Youn-Kyoung Lee; Mary-Elizabeth Patti; C Ronald Kahn
Journal:  Diabetes       Date:  2014-07-24       Impact factor: 9.461

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.